在使用UHPLC-MS/MS的老鼠中,MRTX1133的药理动力学,生物可用性和组织分布
Wei Lu1,2, Rong Zeng3, Meng Pan4
1Department of Pharmacy, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
这项研究描述了MRTX1133的药理动力学,MRTX1133是一种KRAS (G12D) 抑制剂,在临床前模型中显示了快速吸收和广泛分布. 研究结果支持其在未来对固体瘤的临床试验中使用.
科学领域:
- 药理学和毒理学 药理学和毒理学
- 瘤学 药物开发 药物开发
背景情况:
- MRTX1133是一种新型的,选择性抑制剂,向KRAS (G12D) 突变,有望延迟固体瘤的进展.
- 关于MRTX1133的吸收,分布和分泌 (ADME) 概况的数据有限,这对其临床发展至关重要.
研究的目的:
- 开发和验证一种敏感的生物分析方法,用于在生物矩阵中量化MRTX1133.
- 为了研究MRTX1133在老鼠中的药理动力学特性,生物可用性,组织分布和分泌.
主要方法:
- 超高性能液体染色学 - 协同四极质谱学 (UHPLC-MS/MS) 用于MRTX1133的确定.
- 该方法在老鼠血,组织同质物和尿液中的准确性,精度和矩阵效应方面得到了验证.
- 在口服 (25 mg/kg) 和静脉注射 (5 mg/kg) 后评估了药物动力学参数.
主要成果:
- 该UHPLC-MS/MS方法显示出优异的线性 (r2>0.99),准确度 (85-115%) 和精度 (±10%).
- 在口服后,MRTX1133表现出快速吸收 (Tmax 45分钟),Cmax为129.90 ± 25.23 ng/mL.
- 口服生物利用率为2.92%,MRTX1133在主要器官中广泛分布,可在服用后24小时内检测到;脏分泌占22.59%±3.22%.
结论:
- 在临床前模型中,MRTX1133被快速吸收和广泛分布,这表明ADME具有有利的特征.
- 经过验证的生物分析方法为在临床前和临床研究中量化MRTX1133提供了可靠的工具.
- 这些发现为进一步调查MRTX1133在KRAS (G12D) 驱动癌症中的治疗潜力奠定了基础.
更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
08:41Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice
Published on: October 27, 2014
相关概念视频
Noncompartmental Analysis: Mean Transit, Absorption and Dissolution Time
One of the key parameters is the mean transit time (MTT), which refers to the total duration required for drug molecules to transit through the body. MTT is determined by calculating the ratio of the area under the moment curve to the area...
Noncompartmental Analysis: Mean Residence Time
After the administration of a drug through intravenous bolus injection, the drug molecules are distributed throughout the body and remain there for varying periods. The MRT represents the average time these drug molecules stay in the...
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
Tissue-Drug Binding: Localization of Drugs and its Significance
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Bioavailability: Overview
Methods for Studying Drug Absorption: In situ
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
![Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F59557.jpg&w=3840&q=50)